Vote Scores

Home / Companies / COSMOS Pharmaceutical Corp. / 20 Aug 2024

Meeting · year to 30 June 202548 filers reporting

COSMOS Pharmaceutical Corp.: meeting of 20 Aug 2024

Votes reported on Form N-PX, item by item

48 Form N-PX filers reported votes at the COSMOS Pharmaceutical Corp. meeting of 20 Aug 2024. Their records fall into 3 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

3 nominees; 92.1% of reported votes for; 10 filers withheld from or voted against at least one nominee.

216 vote records from 48 filers. 3 of the 48 filers that marked the item either way voted against management.

93.8% for4.2% against2.1% other6.3% against management48 filers
2

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

72 vote records from 48 filers. 30 of the 48 filers that marked the item either way voted against management.

37.5% for62.5% against62.5% against management48 filers82.9% for17.1% against17.1% against management2,629,454 reported shares
3

OTHERIssuer

OTHER: management items

Management items in this category are shown together; filers word and number them differently.

11 vote records from 7 filers. No filer marked a management recommendation, so no against-management figure is reported. 7 filers reported this item without a management mark.

0.0% for0.0% against100.0% other7 filers

How the largest families voted

Family1. Directors2. Auditor
VanguardForFor
BlackRock and iSharesForFor
FidelityForFor
DimensionalForAgainst *
State Street and SPDRForAgainst *
American CenturyForAgainst *
Franklin TempletonForAgainst *
InvescoForAgainst *
EquitableForAgainst *
Charles SchwabForFor
Nuveen and TIAAForAgainst *
Morgan Stanley, Eaton Vance and CalvertAgainst *Against *
J.P. MorganForFor
Goldman SachsForAgainst *
Jackson National fundsForAgainst *
Northern Trust and FlexSharesForAgainst *
Lincoln FinancialForAgainst *
BNY MellonForAgainst *
Capital Group and American FundsForAgainst *
Hartford FundsForFor
Harbor FundsForFor

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the COSMOS Pharmaceutical Corp. meeting?

48 Form N-PX filers reported votes at the meeting of 20 Aug 2024. The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by COSMOS Pharmaceutical Corp. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for COSMOS Pharmaceutical Corp.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing COSMOS Pharmaceutical Corp. with a meeting date within three days of 20 Aug 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.